semaglutide mouse The GLP-1 medicines and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice Semaglutide Attenuates Anxious and Depressive-Like

This claim builds on research from Harvard published in July 2024, which found a significantly increased risk of NAION among semaglutide users, followed by additional studies in January 2025 and warnings from the Danish Medicines Agency

Key Factors Affecting Weight Stability Post-Medication Multiple factors influence whether you maintain your loss or regain weight after stopping semaglutide

However, in the most recent published outcome study TECOS, the authors could show that among patients with T2DM and established cardiovascular disease, sitagliptin did not appear to increase the risk of major adverse cardiovascular events, hospitalization for heart failure, or other adverse events (184)

CGMs were primarily used to treat T1D

For first-time patients, a brief intake with our medical team is required so we can verify there are no contraindications and recommend appropriate dosing

During our discovery (consultation) session, we get to know you, ask the right questions, and determine the best plan recommendation tailored specifically to your needs